Cargando…

Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis

Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex vivo for possible clinical application. They possess a unique immunological profile and regulatory machinery that underline...

Descripción completa

Detalles Bibliográficos
Autores principales: Najar, Mehdi, Martel-Pelletier, Johanne, Pelletier, Jean-Pierre, Fahmi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536322/
https://www.ncbi.nlm.nih.gov/pubmed/33072752
http://dx.doi.org/10.3389/fcell.2020.567813
_version_ 1783590542353891328
author Najar, Mehdi
Martel-Pelletier, Johanne
Pelletier, Jean-Pierre
Fahmi, Hassan
author_facet Najar, Mehdi
Martel-Pelletier, Johanne
Pelletier, Jean-Pierre
Fahmi, Hassan
author_sort Najar, Mehdi
collection PubMed
description Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex vivo for possible clinical application. They possess a unique immunological profile and regulatory machinery that underline their therapeutic effects. They also have the capacity to sense the changes within the tissue environment to display the adequate response. Indeed, there is a close interaction between MSCs and the host cells. Accordingly, MSCs demonstrate encouraging results for a variety of diseases including OA. However, their effectiveness needs to be improved. In this review, we selected to discuss the importance of the immunological features of MSCs, including the type of transplantation and the immune and blood compatibility. It is important to consider MSC immune evasive rather than immune privileged. We also highlighted some of the actions/mechanisms that are displayed during tissue healing including the response of MSCs to injury signals, their interaction with the immune system, and the impact of their lifespan. Finally, we briefly summarized the results of clinical studies reporting on the application of MSCs for the treatment of OA. The research field of MSCs is inspiring and innovative but requires more knowledge about the immunobiological properties of these cells. A better understanding of these features will be key for developing a safe and efficient medicinal product for clinical use in OA.
format Online
Article
Text
id pubmed-7536322
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75363222020-10-16 Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis Najar, Mehdi Martel-Pelletier, Johanne Pelletier, Jean-Pierre Fahmi, Hassan Front Cell Dev Biol Cell and Developmental Biology Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex vivo for possible clinical application. They possess a unique immunological profile and regulatory machinery that underline their therapeutic effects. They also have the capacity to sense the changes within the tissue environment to display the adequate response. Indeed, there is a close interaction between MSCs and the host cells. Accordingly, MSCs demonstrate encouraging results for a variety of diseases including OA. However, their effectiveness needs to be improved. In this review, we selected to discuss the importance of the immunological features of MSCs, including the type of transplantation and the immune and blood compatibility. It is important to consider MSC immune evasive rather than immune privileged. We also highlighted some of the actions/mechanisms that are displayed during tissue healing including the response of MSCs to injury signals, their interaction with the immune system, and the impact of their lifespan. Finally, we briefly summarized the results of clinical studies reporting on the application of MSCs for the treatment of OA. The research field of MSCs is inspiring and innovative but requires more knowledge about the immunobiological properties of these cells. A better understanding of these features will be key for developing a safe and efficient medicinal product for clinical use in OA. Frontiers Media S.A. 2020-09-22 /pmc/articles/PMC7536322/ /pubmed/33072752 http://dx.doi.org/10.3389/fcell.2020.567813 Text en Copyright © 2020 Najar, Martel-Pelletier, Pelletier and Fahmi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Najar, Mehdi
Martel-Pelletier, Johanne
Pelletier, Jean-Pierre
Fahmi, Hassan
Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title_full Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title_fullStr Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title_full_unstemmed Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title_short Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
title_sort mesenchymal stromal cell immunology for efficient and safe treatment of osteoarthritis
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536322/
https://www.ncbi.nlm.nih.gov/pubmed/33072752
http://dx.doi.org/10.3389/fcell.2020.567813
work_keys_str_mv AT najarmehdi mesenchymalstromalcellimmunologyforefficientandsafetreatmentofosteoarthritis
AT martelpelletierjohanne mesenchymalstromalcellimmunologyforefficientandsafetreatmentofosteoarthritis
AT pelletierjeanpierre mesenchymalstromalcellimmunologyforefficientandsafetreatmentofosteoarthritis
AT fahmihassan mesenchymalstromalcellimmunologyforefficientandsafetreatmentofosteoarthritis